HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knott-Craig, C. J. Articles by Danielson, G. K. Search for Related Content PubMed PubMed Citation Articles by Knott-Craig, C. J. Articles by Danielson, G. K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 475-481, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Carcinoid disease of the heart. Surgical management of ten patients

CJ Knott-Craig, HV Schaff, CJ Mullany, LK Kvols, CG Moertel, WD Edwards and GK Danielson
Division of Thoracic and Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. 55905.

Between 1982 and 1989, 10 patients with carcinoid heart disease underwent tricuspid valve replacement with a mechanical prosthesis at our institution. Pulmonary valvectomy was performed in nine patients and pulmonary valve replacement with a pulmonary homograft was performed in one. Two patients had carcinoid tumor metastatic to the heart, involving the right atrium in one case and both ventricles in the other. One patient had concomitant coronary artery bypass with the saphenous vein, and one patient had a quadruple valve replacement for histologically proved carcinoid disease of all four valves. The 30-day mortality was 10% and the late mortality was 30%. The remaining six patients were alive 4, 4, 4, 7, 24, and 46 months postoperatively. A review of the English literature identified 28 additional patients who underwent tricuspid valve replacement for carcinoid heart disease. There was no significant difference in the survival of patients with a bioprosthesis versus a mechanical valve in the tricuspid position. The 4-year survival for the 38 patients undergoing tricuspid valve replacement for carcinoid heart disease was 48% +/- 13%. Symptomatic patients who have carcinoid heart disease and whose metastatic malignant disease is not an imminent threat to life should be offered valve replacement. Operating soon after the onset of increasing cardiac symptoms, before the often rapid deterioration in right ventricular failure, optimizes the benefits.

This article has been cited by other articles:

				J. G. Castillo, F. Filsoufi, D. H. Adams, J. Raikhelkar, B. Zaku, and G. W. Fischer Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist Br. J. Anaesth., November 1, 2008; 101(5): 618 - 626. [Abstract] [Full Text] [PDF]

				L. W. Stephenson History of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 3 - 28. [Full Text]

				H. V. Schaff and R. M. Suri Multiple Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1129 - 1158. [Full Text]

				K. M. Horton, I. Kamel, L. Hofmann, and E. K. Fishman Carcinoid Tumors of the Small Bowel: A Multitechnique Imaging Approach Am. J. Roentgenol., March 1, 2004; 182(3): 559 - 567. [Full Text] [PDF]

				J. O. Wee, J. D. Sepic, T. Mihaljevic, and L. H. Cohn Metastatic carcinoid tumor of the heart Ann. Thorac. Surg., November 1, 2003; 76(5): 1721 - 1722. [Abstract] [Full Text] [PDF]

				L. W. Stephenson History of Cardiac Surgery Card. Surg. Adult, January 1, 2003; 2(2003): 3 - 29. [Full Text]

				H. V. Schaff and D. H. Marsh Multiple Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1017 - 1045. [Full Text]

				H. M. Connolly, H. V. Schaff, C. J. Mullany, M. D. Abel, and P. A. Pellikka Carcinoid Heart Disease: Impact of Pulmonary Valve Replacement in Right Ventricular Function and Remodeling Circulation, September 24, 2002; 106(12_suppl_1): I-51 - I-56. [Abstract] [Full Text] [PDF]

				D. V. Simula, W. D. Edwards, H. D. Tazelaar, H. M. Connolly, and H. V. Schaff Surgical Pathology of Carcinoid Heart Disease: A Study of 139 Valves From 75 Patients Spanning 20 Years Mayo Clin. Proc., February 1, 2002; 77(2): 139 - 147. [Abstract] [PDF]

				H. M. Connolly, H. V. Schaff, C. J. Mullany, J. Rubin, M. D. Abel, and P. A. Pellikka Surgical Management of Left-Sided Carcinoid Heart Disease Circulation, September 18, 2001; 104 (2009): I-36 - I-40. [Abstract] [Full Text] [PDF]

				M. L. McDonald, D. M. Nagorney, H. M. Connolly, R. A. Nishimura, and H. V. Schaff Carcinoid heart disease and carcinoid syndrome: successful surgical treatment Ann. Thorac. Surg., February 1, 1999; 67(2): 537 - 539. [Abstract] [Full Text] [PDF]

				D Vergani, L Massironi, F Lombardi, and C Fiorentini Carcinoid heart disease from ovarian primary presenting with acute pericarditis and biventricular failure Heart, December 1, 1998; 80(6): 623 - 626. [Abstract] [Full Text]

				P. A. Robiolio, V. H. Rigolin, J. S. Wilson, J. K. Harrison, L. L. Sanders, T. M. Bashore, and J. M. Feldman Carcinoid Heart Disease : Correlation of High Serotonin Levels With Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography Circulation, August 15, 1995; 92(4): 790 - 795. [Abstract] [Full Text]